233 related articles for article (PubMed ID: 34350108)
1. Development and External Validation of a Nomogram for Predicting Cancer-Specific Survival of Non-Small Cell Lung Cancer Patients With Ipsilateral Pleural Dissemination.
Wang Z; Li H; Liu T; Sun Z; Yang F; Jiang G
Front Oncol; 2021; 11():645486. PubMed ID: 34350108
[TBL] [Abstract][Full Text] [Related]
2. A novel LASSO-derived prognostic model predicting survival for non-small cell lung cancer patients with M1a diseases.
Chen H; Huang C; Ge H; Chen Q; Chen J; Li Y; Chen H; Luo S; Zhao L; Xu X
Cancer Med; 2022 Mar; 11(6):1561-1572. PubMed ID: 35128839
[TBL] [Abstract][Full Text] [Related]
3. Development and validation of a nomogram for predicting cancer-specific survival of surgical resected stage I-II adenosquamous carcinoma of the lung.
Li H; Wang Z; Yang F; Wang J
J Surg Oncol; 2020 May; 121(6):1027-1035. PubMed ID: 32026478
[TBL] [Abstract][Full Text] [Related]
4. Gender-specific nomogram models to predict the prognosis of male and female lung adenocarcinoma patients: a population-based analysis.
Wen H; Lin X; Sun D
Ann Transl Med; 2021 Nov; 9(22):1654. PubMed ID: 34988163
[TBL] [Abstract][Full Text] [Related]
5. Primary tumor resection of non-small cell lung cancer patients with ipsilateral pleural dissemination (M1a) in the era of targeted therapy.
Li H; Liu T; Sun Z; Yang F
Thorac Cancer; 2020 Nov; 11(11):3213-3222. PubMed ID: 32946207
[TBL] [Abstract][Full Text] [Related]
6. Development and validation of nomogram prognostic model for early-stage T1-2N0M0 small cell lung cancer: A population-based analysis.
Ge T; Zhu S; Sun L; Yin L; Dai J; Qian J; Chen X; Zhang P; Zhu J; Jiang G
Front Oncol; 2022; 12():921365. PubMed ID: 36465408
[TBL] [Abstract][Full Text] [Related]
7. A nomogram prognostic model for large cell lung cancer: analysis from the Surveillance, Epidemiology and End Results Database.
Lin G; Qi K; Liu B; Liu H; Li J
Transl Lung Cancer Res; 2021 Feb; 10(2):622-635. PubMed ID: 33718009
[TBL] [Abstract][Full Text] [Related]
8. Nomogram Predicting the Prognosis of Patients with Surgically Resected Stage IA Non-small Cell Lung Cancer.
Deng XF; Dai Y; Liu XQ; Qi HZ; Zhou D; Zheng H; Li J; Liu QX
Indian J Surg Oncol; 2023 Jun; 14(2):376-386. PubMed ID: 37324285
[TBL] [Abstract][Full Text] [Related]
9. Construction of a nomogram predicting the overall survival of patients with distantly metastatic non-small-cell lung cancer.
Deng J; Ren Z; Wen J; Wang B; Hou X; Xue Z; Chu X
Cancer Manag Res; 2018; 10():6143-6156. PubMed ID: 30538562
[TBL] [Abstract][Full Text] [Related]
10. Primary tumour resection in non-small-cell lung cancer patients with ipsilateral pleural dissemination (M1a): a population-based study.
Li H; Sun Z; Yang F; Sui X; Liu T; Wang J
Eur J Cardiothorac Surg; 2019 Jun; 55(6):1121-1129. PubMed ID: 30726889
[TBL] [Abstract][Full Text] [Related]
11. Development and validation of a prognostic nomogram for early stage non-small cell lung cancer: a study based on the SEER database and a Chinese cohort.
Zhou L; Zhang Y; Chen W; Niu N; Zhao J; Qi W; Xu Y
BMC Cancer; 2022 Sep; 22(1):980. PubMed ID: 36104656
[TBL] [Abstract][Full Text] [Related]
12. The prognosis after contraindicated surgery of NSCLC patients with malignant pleural effusion (M1a) may be better than expected.
Ren Y; Dai C; Shen J; Liu Y; Xie D; Zheng H; He J; Liang W; Jiang G; Fei K; Yang P; He J; Chen C
Oncotarget; 2016 May; 7(18):26856-65. PubMed ID: 27057627
[TBL] [Abstract][Full Text] [Related]
13. Development and validation of nomogram combining serum biomarker for predicting survival in patients with resected rectal cancer.
Fan S; Li T; Zhou P; Peng Q; Zhu Y
Biosci Rep; 2019 Nov; 39(11):. PubMed ID: 31693739
[TBL] [Abstract][Full Text] [Related]
14. Development and external validation of a nomogram predicting overall survival after curative resection of colon cancer.
Wang S; Liu Y; Shi Y; Guan J; Liu M; Wang W
J Int Med Res; 2021 May; 49(5):3000605211015023. PubMed ID: 33990147
[TBL] [Abstract][Full Text] [Related]
15. A Nomogram for Predicting Cancer-Specific Survival of TNM 8th Edition Stage I Non-small-cell Lung Cancer.
Zeng Y; Mayne N; Yang CJ; D'Amico TA; Ng CSH; Liu CC; Petersen RH; Rocco G; Brunelli A; Liu J; Liu Y; Huang W; He J; Wang W; Jiang L; Cui F; Wang W; Liang W; He J;
Ann Surg Oncol; 2019 Jul; 26(7):2053-2062. PubMed ID: 30900105
[TBL] [Abstract][Full Text] [Related]
16. Development and validation of nomograms for predicting overall and cancer-specific survival in young patients with non-small cell lung cancer.
Peng Y; Sun Y
J Thorac Dis; 2020 Apr; 12(4):1404-1416. PubMed ID: 32395278
[TBL] [Abstract][Full Text] [Related]
17. A nomogram for predicting overall survival in patients with resected non-small cell lung cancer treated with chemotherapy.
Zeng Y; Mayne N; Yang CJ; Liu J; Cui F; Li J; Liang W; He J;
Transl Lung Cancer Res; 2021 Apr; 10(4):1690-1699. PubMed ID: 34012785
[TBL] [Abstract][Full Text] [Related]
18. Survival Nomogram for Stage IB Non-Small-Cell Lung Cancer Patients, Based on the SEER Database and an External Validation Cohort.
Zuo Z; Zhang G; Song P; Yang J; Li S; Zhong Z; Tan Q; Wang L; Xue Q; Gao S; Sun N; He J
Ann Surg Oncol; 2021 Jul; 28(7):3941-3950. PubMed ID: 33249521
[TBL] [Abstract][Full Text] [Related]
19. A nomogram to predict prognosis in patients undergoing sublobar resection for stage IA non-small-cell lung cancer.
Yang H; Li X; Shi J; Fu H; Yang H; Liang Z; Xiong H; Wang H
Cancer Manag Res; 2018; 10():6611-6626. PubMed ID: 30584357
[TBL] [Abstract][Full Text] [Related]
20. The role of surgery for atypical bronchopulmonary carcinoid tumor: Development and validation of a model based on Surveillance, Epidemiology, and End Results (SEER) database.
Chen X; Pang Z; Wang Y; Bie F; Zeng Y; Wang G; Du J
Lung Cancer; 2020 Jan; 139():94-102. PubMed ID: 31759223
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
